Cardiff Lexington Corp awarded director Catherine B. Pennington 500,000 derivative securities on 2026-09-08, with the transaction classified as code A. For investors, the award accounts for about 100.0% of Pennington’s resulting derivative securities holding, making it the full position identified after the transaction.
Key Highlights
- Catherine B. Pennington held 500,000 derivative securities after the transaction.
- The transaction occurred on 8 September 2026 and was classified under code A.
- Cardiff Lexington Corp awarded director Catherine B. Pennington 500,000 derivative securities on 8 September 2026.
Cardiff Lexington Corp (NASDAQ: CDIX) awarded director Catherine B. Pennington 500,000 derivative securities on 8 September 2026. The transaction classified the award under code A. Catherine B. Pennington is identified as a director of Cardiff Lexington Corp. The transaction concerns derivative securities associated with the company and records an award to the named director.
Resulting Holding Represents 100.0% of Position
Pennington owned 500,000 derivative securities after the transaction. The award represented about 100.0% of her resulting derivative securities holding.
FAQs
Q: What did Cardiff Lexington Corp award Catherine B. Pennington?
A: Cardiff Lexington Corp awarded director Catherine B. Pennington 500,000 derivative securities on 8 September 2026. The transaction was classified under code A.
Q: How many derivative securities did Catherine B. Pennington own after the transaction?
A: Catherine B. Pennington owned 500,000 derivative securities after the Cardiff Lexington transaction. She is identified as a director of the company.
Q: What percentage of Catherine B. Pennington’s resulting holding did the transaction represent?
A: The transaction represented about 100.0% of Catherine B. Pennington’s resulting derivative securities holding. The reported post-transaction position was 500,000 derivative securities.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.